Produced in partnership with
The Society for
Cardiac Angiography and Interventions 
www.scai.org

View SCAI Privacy Policy

eDebate:
Renal stenting: Do we need another trial?

This event was recorded on:
Wednesday, September 3, 2003

Course ID: AA0212

 [View Recording] (26 Megabytes)

Supported by an educational grant from:

www.pfizer.com

Protagonist
Christopher J. Cooper, MD
Division of Cardiology, Department of Medicine Medical College of Ohio, Toledo, OH
Disclosures: Grant support from Cordis, Centrocor, Esperion, and AstraZeneca.

Moderator:
Joseph Babb, MD, FACC, FSCAI
Professor of Medicine, East Carolina University School of Medicine; Director, Cardiac Catheterization Laboratories, Pitt County Memorial Hospital, Greenville, NC.
Disclosures: No relationship with a commercial party to disclose.

Overview

Clinical studies looking at renal stenting point to high survival rates for patients with renal artery stenosis and at least some success in lowering risk factors such as hypertension. ASPIRE 2, a multicenter prospective nonrandomized trial involving 208 patients, reported restenosis rates equal to or better than those previously reported in the clinical literature. Stent placement was successful in 99.6% of patients, with a restenosis rate of 17.4% at 9-month follow-up with duplex ultrasound. The ASPIRE 2 trial validated a number of smaller single institution studies; however, the procedure does have limits. In another study, investigators at Dartmouth-Hitchcock Medical Center found that patients with creatinine levels lower than 3 mg/dL are the ones most likely to have a successful renal function salvage, while hypertensive patients experience varying degrees of improvement. Investigators at that institution believe that while a link between intervention and a lower risk of cardiovascular events is possible, this should be validated by case-controlled or prospective randomized trials.

In this point/counterpoint debate, Dr. Cooper (pro) and Dr. White (con) will discuss clinical studies to date on renal stenting and will argue whether more studies are needed to determine which patients would most benefit from this procedure.

Learning Objectives

Upon completion of this course, you should be able to:

• List the major studies of renal stenting and their importance in clinical practice
• Determine patient types that are most likely to benefit from renal stenting
• Understand the pros and cons of conducting future clinical studies in renal stenting

Learner Participation to Earn Credit

To earn a CME certificate, you must:

• view the Instant Replay recording of event
  

• Complete online program evaluation

Computer Requirements to Participate

Click here to view the computer requirements to participate in this activity.

Target Audience

This program will be of special interest to invasive and interventional cardiologists, fellows-in-training, cath lab nurses, technologists, technicians, and staff.

Accreditation Period

This activity was approved for AMA category 1 credit for two years from the original release date of September 3, 2003. After September 3, 2005 it will no longer be certified for credit, but may still have value for the healthcare provider.

Accreditation Statement

Continuing Medical Education for Physicians
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Society for Cardiac Angiography and Interventions (SCAI) and CEU-Online. The SCAI is accredited by the ACCME to provide continuing medical education for physicians.

The Society for Cardiac Angiography and Interventions designates this educational activity for a maximum of one category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only the credit that he/she actually spent in the activity.

Questions Regarding This Event

Please click here to e-mail any questions you have regarding this activity.

As an organization accredited for continuing medical education (CME), SCAI fully complies with the legal requirements of the Americans with Disabilities Act rules and regulations. If any participant is in need of accommodations, written requests should be submitted as soon as possible.

Course Certificate Fees

These events are produced in partnership with SCAI and MEBN.NET and are FREE for SCAI members thanks to a generous grant from Pfizer.